. 2020 Jan 24;4:160. Originally published 2019 Oct 23. [Version 2] doi: 10.12688/wellcomeopenres.15514.2

Table 5. Longitudinal ESBL prevalence in included cohort studies.

NR = not reported. * = median not given but admission length was 2–10 days.

Study	Study population	ESBL prevalence		Median follow up
Study	Study population	Admission	Discharge	Median follow up
Andriatahina 2010	Children	51/244 (21%)	88/154 (57%)	5.7d
Woerther 2011	Children	17/55 (31%)	15/16 (94%)	8d
Nelson 2014	Neonates	32/126 (25%)	77/126 (61%)	7d
Kurz 2016	Adults and children	195/392 (50%)	173/208 (83%)	6d
Magwenzi 2017	Children	86/164 (52%)	115/164 (70%)	5.6d
Moremi 2018	Adults	220/930 (24%)	143/272 (53%)	NR *